Irene Della Starza Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

3/2024	Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient.
2/2023	Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irene Della Starza Research Topics

Disease

11	Residual Neoplasm 02/2023 - 05/2014
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2023 - 02/2007
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2023 - 02/2014
4	Neoplasms (Cancer) 02/2023 - 04/2011
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2023 - 05/2005
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2024 - 09/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2024 - 02/2023
2	Hematologic Neoplasms (Hematological Malignancy) 02/2023 - 01/2023
2	Philadelphia Chromosome 01/2023 - 04/2011
2	Lymphoma (Lymphomas) 01/2023 - 01/2021
1	Primary Effusion Lymphoma 03/2024
1	Castleman Disease (Castleman's Disease) 03/2024
1	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2024
1	Acute Disease 02/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2023
1	Disease Progression 12/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2011
1	Leukemia 04/2011
1	Pathologic Complete Response 02/2007

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 02/2023 - 05/2014
3	Rituximab (Mabthera)FDA Link 12/2021 - 05/2005
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 05/2005
2	Cell-Free Nucleic AcidsIBA 02/2023 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 12/2020 - 08/2016
2	fludarabineIBA 11/2020 - 02/2014
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 04/2011
1	CytokinesIBA 03/2024
1	PromegaIBA 02/2023
1	pegaspargase (Oncaspar)FDA Link 01/2023
1	ibrutinibIBA 12/2021
1	ponatinibIBA 01/2021
1	AntigensIBA 01/2021
1	ElementsIBA 12/2020
1	ofatumumab FDA Link 11/2020
1	Clofarabine (Clolar)FDA Link 12/2019
1	Drug CombinationsIBA 01/2019
1	Diatrizoate (Hypaque)FDA LinkGeneric 01/2018
1	FicollIBA 01/2018
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2014
1	Alemtuzumab (Campath)FDA Link 02/2014
1	Phosphotransferases (Kinase)IBA 04/2011
1	Tyrosine (L-Tyrosine)FDA Link 04/2011
1	Vincristine (Oncovin)FDA LinkGeneric 05/2005
1	Prednisone (Sone)FDA LinkGeneric 05/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2005

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2023 - 01/2020
2	Therapeutics 01/2019 - 02/2007
1	Cell Transplantation 01/2023
1	Radiotherapy 01/2020